
TY  - JOUR
TI  - Swiss Society of Surgery
JO  - BJS (British Journal of Surgery)
JA  - Br J Surg
VL  - 95
IS  - S2
SN  - 0007-1323
UR  - https://doi.org/10.1002/bjs.6206
DO  - doi:10.1002/bjs.6206
SP  - 1
EP  - 26
PY  - 2008
AB  - Abstract The following abstracts were presented at the 95th Annual Congress of the Swiss Society of Surgery. The meeting, held in Basel 28?30 May 2008, is organized for the sixth time in collaboration with the Swiss Society of Thoracic, Heart and Vascular Surgery. To view the abstracts from this meeting, please click the pdf link on this page. Copyright ? 2008 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 52
IS  - S47
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.23840
DO  - doi:10.1002/ppul.23840
SP  - S214
EP  - S516
PY  - 2017
ER  - 

TY  - JOUR
AU  - Toebak, Mascha J.
AU  - Gibbs, Susan
AU  - Bruynzeel, Derk P.
AU  - Scheper, Rik J.
AU  - Rustemeyer, Thomas
TI  - Dendritic cells: biology of the skin
JO  - Contact Dermatitis
VL  - 60
IS  - 1
SN  - 0105-1873
UR  - https://doi.org/10.1111/j.1600-0536.2008.01443.x
DO  - doi:10.1111/j.1600-0536.2008.01443.x
SP  - 2
EP  - 20
KW  - allergen
KW  - allergic contact dermatitis
KW  - animal alternative
KW  - dendritic cell
KW  - dermal dendritic cell
KW  - irritant
KW  - Langerhans’ cell
KW  - predictive testing for allergenicity
KW  - skin immunology
PY  - 2009
AB  - Allergic contact dermatitis results from a T-cell-mediated, delayed-type hypersensitivity immune response induced by allergens. Skin dendritic cells (DCs) play a central role in the initiation of allergic skin responses. Following encounter with an allergen, DCs become activated and undergo maturation and differentiate into immunostimulatory DCs and are able to present antigens effectively to T cells. The frequency of allergic skin disorders has increased in the past decades. Therefore, the identification of potential sensitizing chemicals is important for skin safety. Traditionally, predictive testing for allergenicity has been conducted in animal models. For regulatory reasons, animal use for sensitization testing of compounds for cosmetic purposes is shortly to be prohibited in Europe. Therefore, new non-animal-based test methods need to be developed. Several DC-based assays have been described to discriminate allergens from irritants. Unfortunately, current in vitro methods are not sufficiently resilient to identify allergens and therefore need refinement. Here, we review the immunobiology of skin DCs (Langerhans? cells and dermal dendritic cells) and their role in allergic and irritant contact dermatitis and then explore the possible use of DC-based models for discriminating between allergens and irritants.
ER  - 

TY  - JOUR
TI  - Posters (Abstracts 301–2389)
JO  - Hepatology
JA  - Hepatology
VL  - 68
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.30257
DO  - doi:10.1002/hep.30257
SP  - 184
EP  - 1353
PY  - 2018
ER  - 

TY  - JOUR
TI  - ABSTRACTS—POSTERS
JO  - Alcoholism: Clinical and Experimental Research
VL  - 33
IS  - s1
SN  - 0145-6008
UR  - https://doi.org/10.1111/j.1530-0277.2009.00957.x
DO  - doi:10.1111/j.1530-0277.2009.00957.x
SP  - 11A
EP  - 265A
PY  - 2009
ER  - 

TY  - JOUR
TI  - ABSTRACTS – Online Panel Discussion (i-Pos)
JO  - International Journal of Rheumatic Diseases
VL  - 11
IS  - s1
SN  - 1756-1841
UR  - https://doi.org/10.1111/j.1479-8077.2008.00373.x
DO  - doi:10.1111/j.1479-8077.2008.00373.x
SP  - A84
EP  - A514
PY  - 2008
ER  - 

TY  - JOUR
TI  - Poster Sessions: Basic
JO  - American Journal of Transplantation
VL  - 14
IS  - S3
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.12888
DO  - doi:10.1111/ajt.12888
SP  - 278
EP  - 419
PY  - 2014
ER  - 

TY  - JOUR
C7  - 18438
TI  - Workshop Sessions
JO  - Journal of the International AIDS Society
VL  - 15
IS  - S3
SN  - 1758-2652
UR  - https://doi.org/10.7448/IAS.15.5.18438
DO  - doi:10.7448/IAS.15.5.18438
SP  - 18438
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts—Posters
JO  - Immunology
JA  - Alcohol Clin Exp Re
VL  - 137
IS  - s1
SN  - 0019-2805
UR  - https://doi.org/10.1111/imm.12001
DO  - doi:10.1111/imm.12001
SP  - 1
EP  - 184
PY  - 2012
ER  - 

TY  - JOUR
TI  - ASBMR 2010 Annual Meeting SU0001–SU0482
JO  - Alcoholism: Clinical and Experimental Research
JA  - J Bone Miner Res
VL  - 43
IS  - S1
SN  - 0145-6008
UR  - https://doi.org/10.1111/acer.14059
DO  - doi:10.1111/acer.14059
SP  - 27A
EP  - 258A
PY  - 2019
ER  - 

TY  - JOUR
TI  - SMR Congress 2017 abstracts
JO  - Journal of Bone and Mineral Research
JA  - Pigment Cell Melanoma Res.
VL  - 25
IS  - S1
SN  - 0884-0431
UR  - https://doi.org/10.1002/jbmr.5650251304
DO  - doi:10.1002/jbmr.5650251304
SP  - S225
EP  - S362
PY  - 2010
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Pigment Cell & Melanoma Research
JA  - Am J Transplant
VL  - 31
IS  - 1
SN  - 1755-1471
UR  - https://doi.org/10.1111/pcmr.12656
DO  - doi:10.1111/pcmr.12656
SP  - 125
EP  - 230
PY  - 2018
ER  - 

TY  - JOUR
AU  - Van de Walle, Gerlinde R.
AU  - De Schauwer, Catharina
AU  - Fortier, Lisa A.
TI  - Mesenchymal Stem Cell Therapy
JO  - American Journal of Transplantation
VL  - 16
IS  - S3
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.13898
DO  - doi:10.1111/ajt.13898
SP  - 405
EP  - 798
KW  - equine MSC
KW  - equine MSC
KW  - equine regenerative medicine
KW  - mesenchymal stem cell therapy
PY  - 2016
AB  - Summary The use of mesenchymal stem cell (MSC) for the treatment of equine injuries and diseases holds immense potential, and is expanding from its original application in orthopedics into the treatment of ischemic, inflammatory, and neurologic disorders. The use of MSC for primary tissue regeneration was initially advocated on the basis of their ability to differentiate into various tissue types. As such, the regeneration of damaged tissues would be directly stimulated, since injected MSC colonize the injury site, differentiate into the appropriate mesenchymal tissue type, and affect repair. Since 2003, the clinical use of MSC has exploded, with thousands of horses now being treated worldwide. Demonstrating true efficacy should be a collective goal of the equine veterinary community, by performing clinical trials that include a sufficient amount of similar cases, and a consistent and standardized panel of objective outcome measures.
ER  - 

C7  - pp. 297-310
TI  - Abstract Presentations from the AABB Annual Meeting Anaheim, CA, October 24–27, 2015
SN  - 9781118558874
UR  - https://doi.org/10.1002/9781119086512.ch31
DO  - doi:10.1002/9781119086512.ch31
SP  - 297-310
PY  - 2016
ER  - 

TY  - JOUR
AU  - Abrahimi, P.
AU  - Liu, R.
AU  - Pober, J. S.
TI  - Blood Vessels in Allotransplantation
JO  - Transfusion
VL  - 55
IS  - S3
SN  - 9781118558874
UR  - https://doi.org/10.1111/trf.13294
DO  - doi:10.1111/trf.13294
SP  - 3A
EP  - 245A
KW  - Editorial
KW  - immunobiology
KW  - organ transplantation in general
KW  - personal viewpoint
KW  - rejection: antibody-mediated (ABMR)
KW  - rejection: chronic
KW  - rejection: T cell-mediated (TCMR)
KW  - rejection: vascular
KW  - vascular biology
PY  - 2015
AB  - Human vascularized allografts are perfused through blood vessels composed of cells (endothelium, pericytes, and smooth muscle cells) that remain largely of graft origin and are thus subject to host alloimmune responses. Graft vessels must be healthy to maintain homeostatic functions including control of perfusion, maintenance of permselectivity, prevention of thrombosis, and participation in immune surveillance. Vascular cell injury can cause dysfunction that interferes with these processes. Graft vascular cells can be activated by mediators of innate and adaptive immunity to participate in graft inflammation contributing to both ischemia/reperfusion injury and allograft rejection. Different forms of rejection may affect graft vessels in different ways, ranging from thrombosis and neutrophilic inflammation in hyperacute rejection, to endothelialitis/intimal arteritis and fibrinoid necrosis in acute cell-mediated or antibody-mediated rejection, respectively, and to diffuse luminal stenosis in chronic rejection. While some current therapies targeting the host immune system do affect graft vascular cells, direct targeting of the graft vasculature may create new opportunities for preventing allograft injury and loss.
ER  - 

TY  - JOUR
TI  - Full Oral
JO  - American Journal of Transplantation
JA  - Transpl Int
VL  - 15
IS  - 7
SN  - 9781118558874
UR  - https://doi.org/10.1111/ajt.13242
DO  - doi:10.1111/ajt.13242
SP  - 1748
EP  - 1754
PY  - 2015
ER  - 

TY  - JOUR
TI  - 20th Annual Symposium on Nonhuman Primate Models for AIDS
JO  - Transplant International
VL  - 32
IS  - S2
SN  - 9781118558874
UR  - https://doi.org/10.1111/tri.13507
DO  - doi:10.1111/tri.13507
SP  - 7
EP  - 126
PY  - 2019
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Medical Primatology
JA  - Br J Haematol
VL  - 32
IS  - 4‐5
SN  - 9781118558874
UR  - https://doi.org/10.1034/j.1600-0684.2003.00033.x
DO  - doi:10.1034/j.1600-0684.2003.00033.x
SP  - 265
EP  - 305
PY  - 2003
ER  - 

TY  - JOUR
TI  - Abstracts TPS
JO  - British Journal of Haematology
JA  - Allergy
VL  - 169
IS  - s1
SN  - 9781118558874
UR  - https://doi.org/10.1111/bjh.13350
DO  - doi:10.1111/bjh.13350
SP  - 1
EP  - 104
PY  - 2015
ER  - 

TY  - JOUR
TI  - Abstracts TPS
JO  - Allergy
VL  - 73
IS  - S105
SN  - 9781118558874
UR  - https://doi.org/10.1111/all.13539
DO  - doi:10.1111/all.13539
SP  - 370
EP  - 702
PY  - 2018
ER  - 
